IP Verse

Method For The Production Of Polypeptides - EP2828396

The patent EP2828396 was granted to Richter Gedeon Nyrt on Apr 24, 2019. The application was originally filed on Mar 18, 2013 under application number EP13709469A. The patent is currently recorded with a legal status of "Revoked".

EP2828396

RICHTER GEDEON NYRT
Application Number
EP13709469A
Filing Date
Mar 18, 2013
Status
Revoked
Sep 18, 2020
Grant Date
Apr 24, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TRUSCOTTJan 13, 2020ADMISSIBLE

Patent Citations (36) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0169566
DESCRIPTIONEP0219874
DESCRIPTIONEP0237545
DESCRIPTIONEP0364926
DESCRIPTIONEP0401384
DESCRIPTIONEP0512097
DESCRIPTIONEP0719860
DESCRIPTIONEP1630173
DESCRIPTIONEP1837346
DESCRIPTIONUS5055555
DESCRIPTIONUS5681720
DESCRIPTIONUS5849883
DESCRIPTIONUS6489450
DESCRIPTIONWO0002901
DESCRIPTIONWO0104154
DESCRIPTIONWO0187925
DESCRIPTIONWO03051922
DESCRIPTIONWO2004001056
DESCRIPTIONWO2004015124
DESCRIPTIONWO2006097944
DESCRIPTIONWO2006135176
DESCRIPTIONWO2008096370
DESCRIPTIONWO2010146599
DESCRIPTIONWO8701132
DESCRIPTIONWO8910932
DESCRIPTIONWO9853072
EXAMINATIONWO2008096368
INTERNATIONAL-SEARCH-REPORTCN101691560
INTERNATIONAL-SEARCH-REPORTWO2004015124
OPPOSITIONCN101691560
OPPOSITIONWO2004015124
OPPOSITIONWO2008096368
OTHEREP2828396
OTHERWO2004015124
OTHERWO2008009368
OTHERWO2008096368

Non-Patent Literature (NPL) Citations (23) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Novagen, "pET-22b(+) Vector", Novagen @BULLET ORDERING 800-526-7319 @BULLET TECHNICAL SUPPORT 800-207-0144, (19981201), URL: https://plasmid.med.harvard.edu/PlasmidRepository/file/map/pET22b(+).pdf, (20170531), XP055377716-
EXAMINATION- Park Se-Cheol ET AL, "Production of Soluble Recombinant Human Granulocyte Colony Stimulating Factor in E. coli by Control of Growth Rate", Korean Journal of Microbiology and Biotechnology, vol 32, No.2, South Korea, (20040601), pages 135 - 141, URL: https://portal.koreascience.or.kr/article/articleresultdetail.jsp?no=MSMSBV_2004_v32n2_135, (20161213), XP055328560-
EXAMINATION- PETER NEUBAUER, FAHNERT BEATRIX, LILIE HAUKE, VILLAVERDE ANTONIO, SHIVELY JESSUP M, "Protein Inclusion Bodies in Recombinant Bacteria", MICROBIOLOGY MONOGRAPHS: INCLUSIONS IN PROKARYOTES, Berlin/Heidelberg, (20060412), vol. 1, doi:10.1007/7171_009, ISSN 1862-5576, ISBN 978-3-540-26205-3, pages 237 - 292-
EXAMINATION- Se-Cheol Park ET AL, "Translation of: Production of soluble recombinant human granulocyte colony stimulating factor in E. coli by control of growth rate", Korean Journal of Microbiology and Biotechnology, 32(2), South Korea, (20040601), pages 135 - 141, URL: https://portal.koreascience.or.kr/article/articleresultdetail.jsp?no=MSMSBV_2004_v32n2_135, (20161216), XP055329753-
EXAMINATION- DUBENDORF J W ET AL, "Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 219, no. 1, doi:10.1016/0022-2836(91)90856-2, ISSN 0022-2836, (19910505), pages 45 - 59, (19910505), XP024021410
EXAMINATION- DE GROOT ET AL, "Effect of temperature on protein quality in bacterial inclusion bodies", FEBS LETT, ELSEVIER, AMSTERDAM, NL, (20061127), vol. 580, no. 27, doi:10.1016/J.FEBSLET.2006.10.071, ISSN 0014-5793, pages 6471 - 6476, XP005773325
EXAMINATION- RACHID SEDDI ET AL, "Expression of a soluble and activatable form of bovine procarboxypeptidase A in Escherichia coli", PROTEIN EXPRESSION AND PURIFICATION., SAN DIEGO, CA., (20030128), vol. 27, no. 2, doi:10.1016/S1046-5928(02)00573-9, ISSN 1046-5928, pages 220 - 228, XP055328362
EXAMINATION- JEVSEVAR SIMONA ET AL, "Production of nonclassical inclusion bodies from which correctly folded protein can be extracted", BIOTECHNOLOGY PROGRESS, AMERICAN INSTITUTE OF CHEMICAL ENGINEERS, US, (20050301), vol. 21, no. 2, doi:10.1021/BP0497839, ISSN 8756-7938, pages 632 - 639, XP002426305
EXAMINATION- SPELA PETERNEL ET AL, "New properties of inclusion bodies with implications for biotechnology", BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, (20080401), vol. 49, no. 4, doi:10.1042/BA20070140, ISSN 0885-4513, page 239, XP055065159
OPPOSITION- Anonymous, "705-Cre, cm", Gene Bridges GmbH, (20181030), URL: https://genebridges.com/products/705-cre-cm, XP055672018-
OPPOSITION- Anonymous, "pET-22b(+) Vector", Novagen Technical Support TB038, (199812), page 2pp, XP055671961-
OPPOSITION- Anonymous, "pET System Manual", Novagen TB055 8th Edition, (199902), pages 1 - 50, XP055672021-
OPPOSITION- "BL21(DE3) Competent Cells, BL21 (DE3) pLysS Competent Cells, and BL21 Competent Cells", Instruction Manual Agilent Technologies, page 1pp, 3-
OPPOSITION- PARK SE-CHEOL et al., "Production of Soluble Recombinant Human Granulocyte Colony Stimulating Factor in E.coli by control of Growth Rate", Korean Journal of Microbiology and Biotechnology, (20040601), vol. 32, no. 2, pages 135 - 141, XP055328560-
OPPOSITION- NEUBAUER et al., "Protein Inclusion Bodies in Recombinant Bacteria", NEUBAUER et al., Shively JM, Inclusions in Prokaryotes, Berlin, Heidelberg, SPRINGER-VERLAG, (20060000), pages 237 - 292, XP055583739
OPPOSITION- DUBENDORF et al., "Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor", J Mol Biol., (19910505), vol. 219, no. 1, pages 45 - 59, XP024021410
OPPOSITION- Natalia SANCHEZ DE GROOT, Salvador VENTURA, "Effect of temperature on protein quality in bacterial inclusion bodies", FEBS letters, vol. 580, no. 27, pages 6471 - 6476, XP028061698
OPPOSITION- YAN JB et al., "High Level expression and purification of Escherichia coli oligopeptidase B", Protein Expr Purif., (20060600), vol. 47, no. 2, pages 645 - 650, XP024908788
OPPOSITION- VIOLAND et al., "Purification and characterization of progenipoietins produced in Escherichia Coli", Protein Expr Purif., (20021100), vol. 26, no. 2, pages 275 - 283, XP055672006
OPPOSITION- RACHID SEDDI et al., "Expression of a soluble and activatable form of bovine procarboxypeptidase A in Escherichia coli", Protein Expression and Purification, (20030300), vol. 27, no. 2, pages 220 - 8, XP055328362
OPPOSITION- JEVSEVAR S et al., "Production of nonclassical inclusion bodies from which correctly folded protein can be extracted", Biotechnology Progress,, (20050300), vol. 21, no. 2, pages 632 - 639, XP002426305
OPPOSITION- PETERNEL S et al., "New properties of inclusion bodies with implications for biotechnology", Biotechnol Appl Biochem., (20080400), vol. 49, no. 4, pages 239 - 246, XP055065159
OPPOSITION- PETERNEL AA PELA et al., "Engineering inclusion bodies for non denaturing extraction of functional proteins", Microbial Cell Factories, (20081201), vol. 7, page 34, XP021049873

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents